865792-18-3(Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one))

865792-18-3 Basic information More..

Product Name:	Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)
Synonyms:	Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one);Cilostazol USP Related Compound C;6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)-butyl]-3,4-dihydro-1H-quinolin-2-one;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone;2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-;Cilostazol related coMpound C;6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyltetrazol-5-yl)butyl]-3,4-dihydroquinolin-2-one;Cilostazol USP RC C
CAS:	865792-18-3
MF:	C31H45N9O2
MW:	575.75
EINECS:
Mol File:	Mol File

Information Error Report

Your Email:

Browse by Nationality 865792-18-3 Suppliers

India(7)	United States(4)	Member(11)	All(12)
United Kingdom(1)

865792-18-3 Recommend Suppliers

Recommend You Select Member Companies.

Company Name:	BOC Sciences Recommend Complaint
Tel:	16314854226
Email:	info@bocsci.com
Nationality:	United States
Products Intro:	Product Name:Cilostazol related compound C CAS:865792-18-3 Purity:>95%
CB Index:	65
WebSite:	www.bocsci.com
Related Information:	Sales Network Catalog(9923) User Evaluation

Company Name:	Cato Research Chemicals Inc. Recommend Complaint
Tel:	+86-020-81960175-877 4000-868-328
Email:	tianwen.zhan@cato-chem.com
Nationality:	United States
Products Intro:	Product Name:Cilostazol USP Related Compound C CAS:865792-18-3 Purity:95%（HPLC） Package:10mg；25mg；50mg；100mg
CB Index:	58
WebSite:	www.cato-chem.com/default.aspx?lang=en
Related Information:	Sales Network Catalog(10404) User Evaluation(1)

Company Name:	Whyte Chemicals Recommend Complaint
Tel:	+44 (20) 8346-5946
Email:	sales@whytechemicals.co.uk
Nationality:	United Kingdom
Products Intro:	Product Name:Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) CAS:865792-18-3 Package:636.00USD/EACH Remarks:1.13419e+006
CB Index:	50
WebSite:	www.whytechemicals.co.uk
Related Information:	Sales Network Catalog(3748) User Evaluation(4)

Company Name:	Olympus Chemicals & Fertilizers Recommend Complaint
Tel:	08068441058Ext 121
Email:
Nationality:	India
Products Intro:	Product Name:Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) CAS:865792-18-3
CB Index:	58
WebSite:	www.chemicalbook.com/ShowSupplierProductsList1333979/0_EN.htm
Related Information:	Sales Network Catalog(486) User Evaluation

Company Name:	Pharma Affiliates Recommend Complaint
Tel:	172-5066494
Email:	@pharmaffiliates.com
Nationality:	India
Products Intro:	Product Name:Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) CAS:865792-18-3
CB Index:	58
WebSite:	www.chemicalbook.com/ShowSupplierProductsList694812/0_EN.htm
Related Information:	Sales Network Catalog(6754) User Evaluation

1 2 3

Tag: 865792-18-3

HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.